(Q36168688)

12 August 2017

1 reference

title

Recent advances in the management of ocular complications of Sjögren's syndrome (English)

1 reference

12 August 2017

Haralampos Moutsopoulos

series ordinal

2

object named as

Haralampos M Moutsopoulos

1 reference

12 August 2017

Michael Samarkos

1

1 reference

12 August 2017

1 July 2005

1 reference

Current Allergy and Asthma Reports

12 August 2017

1 reference

12 August 2017

5

1 reference

12 August 2017

4

1 reference

12 August 2017

327-332

1 reference

https://scigraph.springernature.com/pub.10.1007/s11882-005-0077-x

12 August 2017

0 references

cites work

Tear lipocalin: structure, function and molecular mechanisms of action

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11882-005-0077-X

The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study

21 January 2018

1 reference

12 December 2020

The clinical efficacy of silicone punctal plug therapy

1 reference

12 December 2020

The economic burden of dry eye: a conceptual framework and preliminary assessment

1 reference

12 December 2020

A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome

1 reference

12 December 2020

Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes

1 reference

12 December 2020

Dry eye: diagnosis and current treatment strategies

1 reference

12 December 2020

Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group

1 reference

12 December 2020

Clinical manifestations and early diagnosis of Sjögren syndrome

1 reference

12 December 2020

1 reference

12 December 2020

Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops

1 reference

12 December 2020

Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye

1 reference

12 December 2020

A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca

1 reference

12 December 2020

Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine

1 reference

12 December 2020

Protective Effect ofd-β-Hydroxybutyrate on Corneal Epithelia in Dry Eye Conditions through Suppression of Apoptosis

1 reference

12 December 2020

Blood concentrations of cyclosporin a during long-term treatment with cyclosporin a ophthalmic emulsions in patients with moderate to severe dry eye disease

1 reference

12 December 2020

Albumin as a tear supplement in the treatment of severe dry eye

1 reference

12 December 2020

Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.

1 reference

12 December 2020

Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study

1 reference

12 December 2020

Antiinflammatory therapy for dry eye.

1 reference

12 December 2020

Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group

1 reference

12 December 2020

Treatment of dry eye by autologous serum application in Sjögren's syndrome

1 reference

12 December 2020

Effect of topical cyclosporin A on conjunctival T cells in patients with secondary Sjögren's syndrome

1 reference

12 December 2020

Ocular safety of INS365 ophthalmic solution, a P2Y2 agonist, in patients with mild to moderate dry eye disease.

1 reference

12 December 2020

Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial

1 reference

12 December 2020

Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease

1 reference

12 December 2020

Oral pilocarpine HCl stimulates labial (minor) salivary gland flow in patients with Sjögren's syndrome.

1 reference

12 December 2020

Sialogogic activities of SNI-2011 compared with those of pilocarpine and McN-A-343 in rat salivary glands: identification of a potential therapeutic agent for treatment of Sjörgen's syndrome

1 reference

12 December 2020

The diagnosis and management of dry eye: a twenty-five-year review

1 reference

12 December 2020

Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group

1 reference

12 December 2020

Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.

1 reference

12 December 2020

Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study

1 reference

12 December 2020

Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody

1 reference

12 December 2020

The pathology of dry eye: the interaction between the ocular surface and lacrimal glands

1 reference

12 December 2020

Surgical treatment of dry eye syndrome: conjunctival graft of the minor salivary gland

1 reference

12 December 2020

Cyclosporine has a direct effect on the differentiation of a mucin-secreting cell line

1 reference

12 December 2020

1 reference

12 December 2020

Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study.

1 reference

12 December 2020

Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva.

1 reference

12 December 2020

The treatment of Sjögren's syndrome patients with pilocarpine-tablets

1 reference

12 December 2020

Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjögren's syndrome (SS), and primary SS

1 reference

12 December 2020

Subcutaneous abdominal artificial tears pump-reservoir for severe dry eye.

1 reference

12 December 2020

Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer

1 reference

12 December 2020

Efficacy and retention rate of two types of silicone punctal plugs in patients with and without Sjögren syndrome

1 reference

12 December 2020

Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis

1 reference

12 December 2020

Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome

1 reference

12 December 2020

Therapy of Sjögren's syndrome

1 reference

12 December 2020

Conjunctival epithelial cells from patients with Sjögren's syndrome inappropriately express major histocompatibility complex molecules, La(SSB) antigen, and heat-shock proteins

1 reference

12 December 2020

Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome

1 reference

12 December 2020

Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca

1 reference

12 December 2020

10.1007/S11882-005-0077-X

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15967078